You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.
RabMAbs (1303-1)

Anti-VEGF Receptor 1 antibody [Y103] (ab32152)

Overview

  • Product nameAnti-VEGF Receptor 1 antibody [Y103]See all VEGF Receptor 1 primary antibodies ...
  • Description
    Rabbit monoclonal [Y103] to VEGF Receptor 1
  • Specificityab32152 recognises VEGF receptor 1 and its splice isoform sFlt1.
  • Tested applicationsWB, IHC-P, ICC/IF, IP, Flow Cyt, IHC-Fr more details
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide corresponding to residues in N terminus of human VEGF Receptor 1

  • Positive controlMouse brain tissue, A431 cells, skin cancer.
  • General notesProduced under U.S. Patent No. 5,675,063.

Properties

Applications

Our Abpromise guarantee covers the use of ab32152 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: 1/1000 - 1/5000. Predicted molecular weight: 151 kDa.
IHC-P IHC-P: 1/250.
ICC/IF ICC/IF: 1/250.
IP IP: 1/100.
Flow Cyt Flow Cyt: 1/1000.
IHC-Fr IHC-Fr: 1/250.

Target

  • FunctionReceptor for VEGF, VEGFB and PGF. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. Isoform SFlt1 may have an inhibitory role in angiogenesis.
  • Tissue specificityMostly in normal lung, but also in placenta, liver, kidney, heart and brain tissues. Specifically expressed in most of the vascular endothelial cells, and also expressed in peripheral blood monocytes. It is not expressed in tumor cell lines. Isoform sFlt1 is strongly expressed in placenta.
  • Sequence similaritiesBelongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
    Contains 7 Ig-like C2-type (immunoglobulin-like) domains.
    Contains 1 protein kinase domain.
  • Cellular localizationSecreted and Cell membrane.
  • Target information above from: UniProt accession P17948 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
  • Alternative names
      EC 2.7.10.1 antibodyFlt 1 antibodyFLT antibody
      Flt-1 antibodyFlt1 antibodyFlt1 antibodyFms like tyrosine kinase 1 antibodyFms related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) antibodyFms related tyrosine kinase 1 antibodyFms related tyrosine kinase 1 vascular endothelial growth factor/vascular permeability factor receptor antibodyFms-like tyrosine kinase 1 antibodyFRT antibodySoluble VEGF receptor 1 14 antibodySoluble VEGFR1 variant 2 antibodySoluble VEGFR1 variant 21 antibodyTyrosine protein kinase FRT antibodyTyrosine protein kinase receptor FLT antibodyTyrosine-protein kinase FRT antibodyTyrosine-protein kinase receptor FLT antibodyVascular endothelial growth factor receptor 1 antibodyVascular endothelial growth factor receptor 1 Precursor antibodyVascular endothelial growth factor vascular permeability factor receptor antibodyVascular permeability factor receptor 1 antibodyVascular permeability factor receptor antibodyVEGFR 1 antibodyVEGFR-1 antibodyVEGFR1 antibodyVEGFR1 antibodyVGFR1_HUMAN antibody
    see all

Anti-VEGF Receptor 1 antibody [Y103] images

  • Overlay histogram showing A431 cells stained with ab32152 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab32152, 1/1000 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter.
  • Anti-VEGF Receptor 1 antibody [Y103] (ab32152) at 1/10000 dilution + mouse brain tissue

    Predicted band size : 151 kDa
    Observed band size : 180 kDa (why is the actual band size different from the predicted?)
  • Immunofluorescent analysis of VEGF receptor 1 expression in A431 cells using 1/250 ab32152.
  • Immunohistochemical analysis of VEGF receptor 1 expression in paraffin-embedded skin cancer, using 1/250 ab32152.Immunohistochemical analysis of VEGF receptor 1 expression in paraffin-embedded skin cancer, using 1/250 ab32152.
  • ab32152 at 1/200 dilution staining VEGF Receptor 1 in human 293FT cells by Immunocytochemistry/ Immunofluorescence. Cells were fixed in formaldehyde and blocked in 5% BSA for 1 hour at 25°C. The primary antibody was used at 1/200 dilution in PBS and incubated with sample at 4°C for 12 hours. An Alexa Fluor® 488 conjugated Goat polyclonal to rabbit IgG was used as secondary at 1/500 dilution.

    See Abreview

References for Anti-VEGF Receptor 1 antibody [Y103] (ab32152)

This product has been referenced in:
  • Argiris A  et al. Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck. Ann Oncol 24:220-5 (2013). Human . Read more (PubMed: 22898037) »
  • Chen Q  et al. Homo-catiomer integration into PEGylated polyplex micelle from block-catiomer for systemic anti-angiogenic gene therapy for fibrotic pancreatic tumors. Biomaterials 33:4722-30 (2012). Read more (PubMed: 22444644) »

See all 14 Publications for this product

Product Wall

Filter by Application

Filter by Species

Filter by Ratings

Application Western blot
Sample Mouse Tissue lysate - whole (aorta, kidney)
Loading amount 15 µg
Specification aorta, kidney
Gel Running Conditions Reduced Denaturing (4-15%)
Blocking step Milk as blocking agent for 2 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Mar 25 2011

Application Western blot
Sample Human Cell lysate - whole cell (293FT cells)
Loading amount 50 µg
Specification 293FT cells
Gel Running Conditions Reduced Denaturing
Blocking step Milk as blocking agent for 12 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 4°C
Username

Verified customer

Submitted Sep 01 2010

Application Western blot
Sample Human Cell lysate - whole cell (Pancreatic cancer)
Loading amount 60 µg
Specification Pancreatic cancer
Treatment Curcumin (0, 10, 25, 35, 50 uM) for 24 hrs
Gel Running Conditions Reduced Denaturing (7 %)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Aug 16 2010

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Mouse Tissue sections (Human tumor cells implanted in nude mice)
Specification Human tumor cells implanted in nude mice
Fixative Formaldehyde
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: High pH HIER commercial solution
Blocking step DEEB commercial solution as blocking agent for 10 minute(s) · Concentration: 100%
Username

Verified customer

Submitted Jun 03 2010

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (dermal fibroblasts)
Specification dermal fibroblasts
Fixative Paraformaldehyde
Permeabilization Yes - 0.1 % Triton X 100
Blocking step Serum as blocking agent for 30 minute(s) · Concentration: 2% · Temperature: 20°C
Username

Verified customer

Submitted Feb 25 2010

Application Immunocytochemistry/ Immunofluorescence
Sample Human Cell (293 FT cell line)
Specification 293 FT cell line
Fixative Formaldehyde
Permeabilization No
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Jan 22 2010

Application Immunohistochemistry (Frozen sections)
Sample Mouse Tissue sections (spleen)
Specification spleen
Fixative Paraformaldehyde
Permeabilization No
Blocking step Perkin-Elmer TNB Blocking Reagent as blocking agent for 30 minute(s) · Concentration: 0.5% · Temperature: 25°C
Username

Verified customer

Submitted May 01 2009

Application Western blot
Sample Human Cell lysate - whole cell (Human Umbilical Vein Endothelial Cell)
Loading amount 15 µg
Specification Human Umbilical Vein Endothelial Cell
Treatment +/-VEGF
Gel Running Conditions Reduced Denaturing (4-20% SDS-PAGE)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
Username

Verified customer

Submitted Jun 26 2008

Application Western blot
Sample Mouse Tissue lysate - whole (retina)
Loading amount 20 µg
Specification retina
Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5%
Username

Verified customer

Submitted Mar 20 2007

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"